Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

This study is currently recruiting participants.
Verified March 2013 by Nanjing University School of Medicine
Sponsor:
Collaborators:
Soochow University
Nanjing Medical University
Information provided by (Responsible Party):
Zhi-Hong Liu, M.D., Nanjing University School of Medicine
ClinicalTrials.gov Identifier:
NCT01273844
First received: January 3, 2011
Last updated: March 29, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)